English | 简体中文 | 繁體中文 | 한국어
Lubrizol Delivers Unique Lubricant Solutions for LSPI and Chain Wear
Lubrizol Delivers Unique Lubricant Solutions for LSPI and Chain Wear

News Release

Lubrizol Delivers Unique Lubricant Solutions for LSPI and Chain Wear

CLEVELAND, April 18, 2017 - The Lubrizol Corporation announces its continued work with global OEMs to solve the challenges associated with gasoline direct injection and turbocharged gasoline direct injection (T/GDI) engines. Addressing low speed pre-ignition (LSPI) and chain wear through lubricants is a critical step to achieve more reliable performance in new engines. Lubrizol has developed higher performing lubricant additive technology to address LSPI and chain wear, two challenges specific to T/GDI engines.

ILSAC GF-6, the next major passenger car engine oil specification, has experienced significant delay and is not anticipated to see first license before 2019. This delay has left OEMs to pursue alternative approaches to address T/GDI performance field issues, specifically LSPI and chain wear. LSPI is a random, destructive occurrence caused by high in-cylinder pressures in T/GDI engines. Chain wear is caused by GDI soot, a carbonaceous contaminant unique to T/GDI engines that causes accelerated timing chain wear. It has been proven that advanced lubricant additive technology can have a positive impact on both LSPI and chain wear.

Lubrizol has been persistent in its support of OEMs in their efforts to address these challenges, as evidenced in part by investments in testing and development to discover new ways to mitigate LSPIs detrimental effects and minimize accelerated chain wear. "By working closely with major OEMs to understand T/GDI engine challenges, we've been able to anticipate the needs currently unmet by industry-standard performance," said Gabe Rhoads, passenger car global business manager, Lubrizol Additives."

Many OEMs are evaluating their options to solve LSPI and are taking action. For instance, General Motors has tackled the issue by specifying LSPI performance in its proprietary GM dexos1(TM) Gen 2 specification. Rhoads continues, "OEMs can't afford to wait for a GF-6 remedy to LSPI. They need lubricant solutions now, and they're taking action. That's why Lubrizol has been proactive in developing critical additive technology that enables the necessary performance for T/GDI engines on the road today." Lubrizol anticipates that most OEMs will take similar steps to ensure vehicle field performance.

"In North America, more than 50% of the cars produced in 2017 will be equipped with GDI engines, and by 2024, that figure will rise to 83%. LSPI must be addressed, and it must be addressed now," said Rhoads.

Lubrizol's unique OEM solutions for T/GDI engines are compatible with current ILSAC GF-5 formulations and offer additional protection to mitigate LSPI and minimize chain wear, thus enabling oil marketers to quickly deliver new products to market that are compatible with new OEM specifications.

For more information about Lubrizol's additive solutions for LSPI and OEM-specific needs, contact your Lubrizol representative and visit www.LubrizolAdditives360.com.

About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers' success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,300 employees worldwide. Revenues for 2016 were $6.5 billion. For more information, visit Lubrizol.com.

Media Contact
Meredith Bruder
Website: www.lubrizol.com


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook  
Apr 21, 2018 00:30 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 21:33 ET
BOURBON: Positive progress in negotiations with lenders  
Apr 20, 2018 18:30 ET
Hubbell Incorporated Declares Regular Quarterly Dividend  
Apr 20, 2018 16:01 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 15:23 ET
Heineken Holding N.V. - Amendments to the Articles of Association  
Apr 20, 2018 15:18 ET
Lubrizol Presents Estane® TPU and Other Innovations for Consumer, Industrial, Footwear and Electronics Applications at Chinaplas 2018  
Apr 20, 2018 12:03 ET
Lipotec Active Ingredients Becomes Umbrella Brand  
Apr 19, 2018 23:43 ET
LEH PHARMA LTD.: Company Update  
Apr 18, 2018 19:34 ET
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018  
Apr 18, 2018 19:33 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: